REPORTS

Let’s Pullulate and Expand Your Business

Transmucosal Drug Delivery Market - Global Professional Analysis and Forecast to 2026

Oct 12, 2019  |  158 PAGES  |  REPORT CODE: CMM206572
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Transmucosal Drug Delivery market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.9% during the forecast period.

This report presents the market size and development trends by detailing the Transmucosal Drug Delivery market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Transmucosal Drug Delivery market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Transmucosal Drug Delivery industry and will help you to build a panoramic view of the industrial development.

Transmucosal Drug Delivery Market, By Type:

  • Passive Transdermal Drug Delivery

  • Active Transdermal Drug Delivery

Transmucosal Drug Delivery Market, By Application:

  • Clinics

  • Hospitals

  • Others

Some of the leading players are as follows:

  • Noven Pharmaceuticals, Inc.

  • Tapemark

  • TEVA Pharmaceutical Industries Ltd.

  • Mylan, Inc.

  • DURECT Corporation

  • Apricus BioSciences, Inc

  • Aveva Drug Delivery Systems

  • ALZA Corporation

  • Nemaura Pharma Ltd

  • Corium International, Inc

  • Pantec Biosolutions AG

  • Inovio Pharmaceuticals, Inc.

  • Zosano Pharma

  • Tesa Labtec GmbH

  • 3M Pharmaceuticals

  • Nitto Denko Corporation

  • Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)

  • Antares Pharma, Inc.

  • Generex Biotechnology Corporation

  • Acrux Limited

  • MedPharm LTD

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Transmucosal Drug Delivery Market: Technology Type Analysis

  • 4.1 Transmucosal Drug Delivery Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Transmucosal Drug Delivery Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Passive Transdermal Drug Delivery

    • 4.3.2 Active Transdermal Drug Delivery

5 Transmucosal Drug Delivery Market: Product Analysis

  • 5.1 Transmucosal Drug Delivery Product Market Share Analysis, 2018 & 2026

  • 5.2 Transmucosal Drug Delivery Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Transmucosal Drug Delivery Market: Application Analysis

  • 6.1 Transmucosal Drug Delivery Application Market Share Analysis, 2018 & 2026

  • 6.2 Transmucosal Drug Delivery Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Clinics

    • 6.3.2 Hospitals

    • 6.3.3 Others

7 Transmucosal Drug Delivery Market: Regional Analysis

  • 7.1 Transmucosal Drug Delivery Regional Market Share Analysis, 2018 & 2026

  • 7.2 Transmucosal Drug Delivery Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Noven Pharmaceuticals, Inc.

    • 9.1.1 Noven Pharmaceuticals, Inc. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Tapemark

    • 9.2.1 Tapemark Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 TEVA Pharmaceutical Industries Ltd.

    • 9.3.1 TEVA Pharmaceutical Industries Ltd. Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Mylan, Inc.

    • 9.4.1 Mylan, Inc. Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 DURECT Corporation

    • 9.5.1 DURECT Corporation Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Apricus BioSciences, Inc

    • 9.6.1 Apricus BioSciences, Inc Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Aveva Drug Delivery Systems

    • 9.7.1 Aveva Drug Delivery Systems Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 ALZA Corporation

    • 9.8.1 ALZA Corporation Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Nemaura Pharma Ltd

    • 9.9.1 Nemaura Pharma Ltd Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Corium International, Inc

    • 9.10.1 Corium International, Inc Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Pantec Biosolutions AG

    • 9.11.1 Pantec Biosolutions AG Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Inovio Pharmaceuticals, Inc.

    • 9.12.1 Inovio Pharmaceuticals, Inc. Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Zosano Pharma

    • 9.13.1 Zosano Pharma Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Tesa Labtec GmbH

    • 9.14.1 Tesa Labtec GmbH Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 3M Pharmaceuticals

    • 9.15.1 3M Pharmaceuticals Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Nitto Denko Corporation

    • 9.16.1 Nitto Denko Corporation Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)

    • 9.17.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Antares Pharma, Inc.

    • 9.18.1 Antares Pharma, Inc. Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Generex Biotechnology Corporation

    • 9.19.1 Generex Biotechnology Corporation Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Acrux Limited

    • 9.20.1 Acrux Limited Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 MedPharm LTD

    • 9.21.1 MedPharm LTD Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

 

The List of Tables and Figures (Totals 65 Figures and 127 Tables)

  • Figure Passive Transdermal Drug Delivery Transmucosal Drug Delivery market, 2015 - 2026 (USD Million)

  • Figure Active Transdermal Drug Delivery Transmucosal Drug Delivery market, 2015 - 2026 (USD Million)

  • Figure Clinics market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Transmucosal Drug Delivery market, by country, 2015 - 2026 (USD Million)

  • Table North America Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table North America Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table North America Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Canada Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Canada Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Europe Transmucosal Drug Delivery market, by country, 2015 - 2026 (USD Million)

  • Table Europe Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Europe Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Europe Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Germany Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Germany Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table France Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table France Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Italy Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Italy Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Spain Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Spain Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Transmucosal Drug Delivery market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table China Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table China Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Japan Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Japan Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table India Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table India Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Transmucosal Drug Delivery market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table MEA Transmucosal Drug Delivery market, by country, 2015 - 2026 (USD Million)

  • Table MEA Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table MEA Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table MEA Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Noven Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Tapemark Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table TEVA Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mylan, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DURECT Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Apricus BioSciences, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aveva Drug Delivery Systems Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ALZA Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nemaura Pharma Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Corium International, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pantec Biosolutions AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Inovio Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zosano Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Tesa Labtec GmbH Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table 3M Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nitto Denko Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Antares Pharma, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Generex Biotechnology Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Acrux Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MedPharm LTD Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top